Strong associations between FGF23 and cardiovascular outcome have been reported in studies using composite outcomes including HF-related endpoints and/or all-cause mortality whereas associations with atherosclerosis-related endpoints were less consistent in patient cohorts of MI [14] or coronary artery disease [25]. The gene discussed is FGF23; the disease is hydrops fetalis.